rs142560329
Variant summary
Our verdict is Likely pathogenic. Variant got 7 ACMG points: 7P and 0B. PM2PP3_StrongPP5
The NM_007272.3(CTRC):c.746C>T(p.Pro249Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000558 in 1,613,954 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P249S) has been classified as Uncertain significance.
Frequency
Consequence
NM_007272.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CTRC | NM_007272.3 | c.746C>T | p.Pro249Leu | missense_variant | 7/8 | ENST00000375949.5 | NP_009203.2 | |
CTRC | XM_011540550.2 | c.600C>T | p.Ala200Ala | synonymous_variant | 6/7 | XP_011538852.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CTRC | ENST00000375949.5 | c.746C>T | p.Pro249Leu | missense_variant | 7/8 | 1 | NM_007272.3 | ENSP00000365116.4 | ||
CTRC | ENST00000375943.6 | c.*200C>T | 3_prime_UTR_variant | 4/5 | 1 | ENSP00000365110.2 | ||||
CTRC | ENST00000483406.1 | n.510C>T | non_coding_transcript_exon_variant | 5/6 | 5 |
Frequencies
GnomAD3 genomes AF: 0.000197 AC: 30AN: 152186Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000995 AC: 25AN: 251378Hom.: 0 AF XY: 0.0000809 AC XY: 11AN XY: 135888
GnomAD4 exome AF: 0.0000410 AC: 60AN: 1461650Hom.: 1 Cov.: 34 AF XY: 0.0000454 AC XY: 33AN XY: 727130
GnomAD4 genome AF: 0.000197 AC: 30AN: 152304Hom.: 0 Cov.: 33 AF XY: 0.000201 AC XY: 15AN XY: 74478
ClinVar
Submissions by phenotype
Hereditary pancreatitis Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 08, 2024 | The p.P249L variant (also known as c.746C>T), located in coding exon 7 of the CTRC gene, results from a C to T substitution at nucleotide position 746. The proline at codon 249 is replaced by leucine, an amino acid with some similar properties. In a functional study, this variant was reported in 1 of 1708 affected individuals with chronic pancreatitis. This study also reported this variant showed very little enzyme activity and reduced protein levels (Beer et al. Gut. 2013; 62(11): 1616-24). In addition, this alteration results in substantial disruption of the core structure of CTRC (Ambry internal data). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the available evidence, the clinical significance of this variant remains unclear. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 10, 2023 | This missense change has been observed in individual(s) with pancreatitis (PMID: 18059268, 21631589, 22942235). This sequence change replaces proline, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 249 of the CTRC protein (p.Pro249Leu). This variant is present in population databases (rs142560329, gnomAD 0.1%), and has an allele count higher than expected for a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 566014). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt CTRC protein function. Experimental studies have shown that this missense change affects CTRC function (PMID: 22942235). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
not provided Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Apr 22, 2018 | The CTRC c.746C>T; p.Pro249Leu variant (rs142560329) has been described in individuals with pancreatitis (Cho 2016, Rosendahl 2008) and is observed in the general population at a low frequency of 0.01% (31/277074 alleles) in the Genome Aggregation Database. The proline at codon 249 is highly conserved and computational algorithms (PolyPhen-2, SIFT) predict that this variant is damaging. Additionally, in vitro functional studies of this variant protein demonstrate reduced expression and severe catalytic deficiency (Beer 2013). Based on available information, this variant is considered likely pathogenic. References: Beer S et al. Comprehensive functional analysis of chymotrypsin C (CTRC) variants reveals distinct loss-of-function mechanisms associated with pancreatitis risk. Gut. 2013 Nov;62(11):1616-24. Cho S et al. PRSS1, SPINK1, CFTR, and CTRC Pathogenic Variants in Korean Patients With Idiopathic Pancreatitis. Ann Lab Med. 2016 Nov;36(6):555-60. Rosendahl J et al. Chymotrypsin C (CTRC) variants that diminish activity or secretion are associated with chronic pancreatitis. Nat Genet. 2008 Jan;40(1):78-82. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at